3 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Nuclear Cataract: new trials by email Literature Review of Nuclear Cataract trials Research Report on Nuclear Cataract
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Physiologic Cataract Surgery on Patient Comfort and Medication Usage High IOP Setting, Low IOP Setting - Cataract and IOL Surgery, Cataract Surgery Anesthesia | Not applicable | Not yet recruiting | Matthew Rauen | 85 | 2025-11-01 | 2025-11-10 |
| Minimal Vitrectomy Surgery for Epiretinal Membrane Minimal Vitrectomy Surgery, Conventional Vitrectomy - Epiretinal Membrane, Macular Edema (ME) | Not applicable | Recruiting | Peking Union Medical College Hospital | 140 | 2024-12-01 | 2025-06-13 |
| Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP) High Intraocular Pressure (IOP), Low Intraocular Pressure (IOP) - Nuclear Cataract | Completed | Matthew Rauen | 65 | 2024-03-18 | 2025-05-21 | |
| Microinterventional Endocapsular Nuclear Fragmentation Assisted Cataract Surgery Lens fragmentation - Nuclear Cataract | Not applicable | Unknown | Oogziekenhuis Rotterdam | 80 | 2023-04-03 | 2023-04-10 |
| Phacoemulsification at High IOP and Physiologic IOP: Impact on Anterior and Posterior Segment Physiology High IOP, Low IOP - Nuclear Cataract | Completed | Matthew Rauen | 27 | 2022-09-22 | 2024-01-08 | |
| A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery Dextenza 0.4Mg Ophthalmic Insert - Anterior Chamber Inflammation, Ocular Pain | Completed | Nicole Fram M.D. | 25 | 2021-03-09 | 2021-07-26 | |
| Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract LiquiTears, C-KAD Ophthalmic Solution - Nuclear Cataract | Phase 2 | Unknown | Chakshu Research, Inc. | 81 | 2007-11-01 | 2009-01-21 |
Cataract (1) · Corneal Edema (1) · Epiretinal Membrane (1) · Eye Pain (1) · Macular Edema (1)
Eye Diseases (3) · Corneal Diseases (1) · Eye Manifestations (1) · Lens Diseases (1) · Macular Degeneration (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Retinal Degeneration (1) · Retinal Diseases (1) · Signs and Symptoms (1)
Calcium Dobesilate (1) · Dexamethasone (1)
Matthew Rauen (3) · Chakshu Research, Inc. (1) · Nicole Fram M.D. (1) · Oogziekenhuis Rotterdam (1) · Peking Union Medical College Hospital (1)
United States (4) · China (1) · Nepal (1) · Netherlands (1)
Matthew Rauen, MD (1) · Nicole R Fram, M.D. (1) · Reeta Gurung, MD (1) · Sanduk Ruit, MD (1) · Weihong Yu, MD (1)
PMID 23275902, PMID 25325894, PMID 29074989, PMID 30367938, PMID 30607294, PMID 33199984, PMID 34737914, PMID 35416902, PMID 9209989, PMID 9917782